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Abstract
Background: Giardia lamblia (intestinalis) and Cryptosporidium parvum are the two most important
intestinal parasites infecting North Americans but there is a paucity of active population-based
surveillance data from Canada. This study determined the incidence of and demographic risk
factors for developing Giardia  sp. and Cryptosporidium  sp. infections in a general Canadian
population.
Methods: Population-based laboratory surveillance was conducted among all residents of the
Calgary Health Region (CHR; population ≅ 1 million) during May 1, 1999 and April 30, 2002.
Results: Giardia sp. infection occurred at a rate of 19.6 per 100,000 populations per year. Although
the yearly incidence was stable, a significant seasonal variation was observed with a peak in late
summer to early fall. Males were at higher risk for development of this infection as compared to
females (21.2 vs. 17.9 per 100,000/yr; relative risk (RR) 1.19; 95% confidence interval (CI), 1.00–
1.40, p = 0.047), and there was a significant decrease in risk associated with an increasing age.
Cryptosporidium sp. infection occurred at an overall rate of 6.0 per 100,000 populations per year
although a large outbreak of Cryptosporidium sp. infections occurred in the second half of the
summer of 2001. During August and September of 2001, the incidence of cryptosporidiosis was
55.1 per 100,000 per year as compared to 3.1 per 100,000 per year for the remainder of the
surveillance period (p < 0.0001). Cryptosporidiosis was largely a disease of children with an
incidence of 17.8 per 100,000 per year occurring among those aged < 20 years of age compared to
1.25 per 100,000 per year for adults ≥ 20 years of age (RR 14.19; 95% CI, 9.77–21.11; p < 0.0001).
Conclusion: This study provides important information on the occurrence and demographic risk
groups for acquisition of giardiasis and cryptosporidiosis in a non-selected Canadian population.
Background
Giardia lamblia (intestinalis) and Cryptosporidium parvum
are the two most important intestinal parasites infecting
North Americans [1,2]. Infection with either parasite
occurs when cysts are ingested via contaminated hands,
food and/or water, or through person to person contact
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[3,4]. These infections are associated with endemic infec-
tion rates in many jurisdictions but they have also caused
large outbreaks [5,6]. In Canada, several outbreaks have
been reported in recent decades due to Cryptosporidium
parvum [7,8] and Giardia lamblia [9]. Population-based
surveillance studies conducted in the United States have
demonstrated increasing rates for giardiasis between
1992–97 with the highest national rates being amongst
children aged 0–5 years, followed closely by persons aged
31–40 years [1,10-12]. In the United States in 1997, giar-
diasis cases per 100,000 state population ranged from
0.98 to 42.3 with a national average of 9.5 cases per
100,000 population [1]. Similar true population-based
rates have not been determined for cryptosporidiosis in
North America. Crude estimates from the United States
based on monitoring water contamination show an
expected Cryptosporidium sp. infection rate of between 1–
400 cases per 100,000 population [13].
However, because water-borne transmission is one of the
major routes of acquiring infection, it must also be recog-
nized that infection rates for either enteric parasite may
vary by geographic location. One study in southern
Ontario demonstrated an association between giardiasis
and rural areas and this has been corroborated by subse-
quent GIS spatial scan statistics investigation of clusters of
giardiasis in this area [14]. Although a previously study
had shown significant associations of giardiasis rates with
manure application on agricultural land and livestock
density this was not born out using spatial statistics scan-
ning methods [15].
There is a lack of active population-based data on the dis-
tribution and determinants of Giardia  sp. and Crypt-
osporidium sp. infections in a Canadian population. The
objective of this study was to determine the incidence of
and demographic risk factors for acquiring these infec-
tions among residents of the Calgary Health Region. Such
data is important to establish the burden of disease and
assess risk factors for acquiring these infections in a
defined geographic locale.
Methods
Patients
The Calgary Health Region (CHR) is a well defined, fully
integrated, publicly funded health system that provides
virtually all medical and surgical care to the residents of
the cities of Calgary and Airdrie and several nearby small
towns, villages, and hamlets (2001 population 958,610)
[16]. All residents of the CHR who had a positive stool
specimen for Giardia sp. or Cryptosporidium sp. during the
period from May 1, 1999 and April 30, 2002 were
included in this study.
Study design
A laboratory-based surveillance cohort design was utilized
since all stool samples for parasitological testing are rou-
tinely submitted to a single regional microbiology labora-
tory [i.e., Calgary Laboratory Services (CLS)] [17]. CHR
physicians order stool tests based on the patient's present-
ing symptoms typically of a diarrhoeal illness and the
presence of other risk factors (i.e., recent travel, exposure
to contaminated food or water, immune status etc.).
Because there is universal coverage for healthcare services
including laboratory tests in Canada, lack of health insur-
ance is not a barrier to stool parasitological testing. All
stool samples submitted from community-based or hos-
pital collection sites in the CHR during the study period
were identified by use of the Cerner PathNet Classic ver-
sion 306 (Kansas City, MO) database at Calgary Labora-
tory Services (CLS) [18]. Patients were deemed to have
giardiasis or cryptosporidiosis if an approved diagnostic
test was positive for one or both of these infections
according to the laboratory procedures outlined below.
Once these patients were identified basic demographic
information on age and gender was obtained at CLS and
data were entered manually into an Excel spreadsheet
(Microsoft Corp.).
Laboratory procedures
All stool parasitological tests were performed by Calgary
Laboratory Services (CLS) a large integrated publicly
funded medical laboratory company that provides micro-
biology services from hospitalized and ambulatory
patients 24 hours a day, 7 days a week through a central-
ized facility located in the community. Physicians can
order either a Giardia/Cryptosporidium screen or a full stool
ova and parasite (O & P) examination on the CLS requisi-
tion. Stool parasitological testing proceeded as outlined
below depending on the physician's test request. Only a
G/C EIA screen was done unless a clinical history was pro-
vided on the requisition. All stool specimens that had a
stool O & P procedure were initially screened by the G/C
EIA procedure.
a) Giardia/Cryptosporidium assay
A rapid commercially available immunoassay is initially
performed when a G/C screen is ordered. A stained slide
was also read from all stool samples submitted from chil-
dren ≤ 14 years of age) in order to screen for the presence
of other parasites including Dientamoeba fragilis. Giardia
(GSA 65) and Cryptosporidium (CSA) are specific antigens
produced by the parasites as they multiply within the host
intestinal tract. The ProSpecT®  Giardia/Cryptosporidium
Microplate (Remel Inc., Lenexa, KS, USA) assay (G/C EIA)
is a solid phase immunoassay for the simultaneous detec-
tion of both antigens (GSA 65 and CSA). The G/C EIA was
performed according to the manufacturer's instructions
on unconcentrated formalin-fixed specimens. G/C EIABMC Infectious Diseases 2005, 5:72 http://www.biomedcentral.com/1471-2334/5/72
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tests were considered positive if the optical density was
0.050 ≥ at 450 nm. The Meriflor® G/C direct fluorescent
antibody (DFA) test (Meridian Bioscience Inc., Cincin-
nati, OH) was used to confirm the presence of Giardia
and/or Cryptosporidium infection. One drop (~10 µl) of
the concentrated sediment was thinly spread onto each
well of the treated slide and fluorescence light microscopy
with a 20X objective was used to read the entire well.
b) Stool ova & parasite (stool O & P) method
Stool O & P testing (i.e. stained slide and concentrate)
were only done on samples where the physician had
ordered the test and provided one or more clinical indica-
tions for the request as follows: 1) recent travel outside
North America or Travel Clinic patient, 2) recent immigra-
tion, 3) immune-compromised or specific HIV/AIDS, can-
cer, transplantation clinic locations, 4) request for worms,
tapeworms or Ascaris sp., 5) bloody or bloody stool spec-
imen, 6) Gastroenterologist's patient, and 7) other
(Microbiologist-on-call is consulted). Repeated standard
wash and centrifugation procedures are used to prepare
stool sediment that is stained with Iron Hematoxylin/
Kinyoun stain. The entire 20 × 50 mm cover-slipped
stained smear is scanned with the 10X objective to look
for larger parasitic elements (i.e. ova). The stained slide is
then examined for 10 min. per slide using the 50X oil
immersion lens and confirmation of any parasitic ele-
ments is done under the 100X oil immersion lens. A fecal
concentrate is also prepared using a standard ethyl acetate
concentration method after preparation of the stained
smears. A different technologist reads the concentrate of
the same specimen using both the 10X and 40X dry
objectives.
Analysis
Analyses were performed using Stata version 8.0 (Stata
Corp., College Station, TX). Differences in proportions in
categorical data were compared using Fisher's exact test.
Medians with interquartile ranges (IQR) were used to
report non-normally distributed continuous variables and
were compared using the Wilcoxon Rank-sum test. Inci-
dence rates were calculated using denominator data from
the Alberta Health Registry [19]. Only the first sample
positive in a given study year was included in the analysis.
Category specific risks were calculated and reported as rel-
ative risks (RR) with 95% confidence intervals (CI) as pre-
viously described [20]. Patients were classified as CHR
residents if they had Alberta Health Care numbers and
samples were collected at a CHR site or if they were inpa-
tients in a CHR hospital.
Results
Giardiasis
A total of 562 episodes of Giardia sp. infection were iden-
tified among 552 patients for an overall incidence of 19.6
per 100,000 populations per year. There was no difference
in the yearly incidence of Giardia sp. infection during the
three years of the study (p > 0.2). A significant seasonal
variation was observed with a peak in late summer to early
fall (Figure 1). The incidence rate in the second quarter of
the study (August to October; 31.9 per 100,000/year) was
two times higher (relative risk (RR), 2.06; 95 % confi-
dence interval (CI), 1.74–2.45) than in the other three
quarters (November to July, 15.5 per 100,000/year; p <
0.0001).
A significant association between age and gender and
development of giardiasis was observed (Figure 2). Over-
all males were at slightly higher risk for development of
this infection as compared to females (21.2 vs. 17.9 per
100,000/yr; RR 1.19; 95% CI, 1.00–1.40, p = 0.047).
There was a significant decrease in risk associated with a
increasing age with children and adolescents less than 20
years of age at highest risk (24.6 per 100,000 per year) fol-
lowed by adults aged 20 to 64 (19.4 per 100,000 per year),
and senior adults aged 65 years and older (6.2 per
100,000 per year; p < 0.01 for each pairwise comparison).
Cryptosporidiosis
A total of 173 patients were diagnosed with Cryptosporid-
ium  sp. infection for an overall incidence of 6.0 per
100,000 populations per year. No patients had repeat epi-
sodes of this infection. There was a dramatic difference in
the temporal occurrence of Cryptosporidium sp. infection
during the three years of the study with a large outbreak
occurring in the second half of the summer of 2001 (Fig-
ure 3). During August and September of 2001, 88 patients
were diagnosed with cryptosporidiosis for an incidence of
55.1 per 100,000 per year as compared to 3.1 per 100,000
per year for the remainder of the surveillance period (p <
0.0001).
In contrast to giardiasis where adults remained at notably
increased risk, cryptosporidiosis was primarily a disease of
children and adolescents (Figure 4). A total of 137 (79%)
cases were in individuals < 20 years of age for an incidence
of 17.8 per 100,000 per year as compared to 1.25 per
100,000 per year for adults ≥ 20 years of age (RR 14.19;
95% CI, 9.77–21.11; p < 0.0001). However, these find-
ings are influenced by the fact that significant differences
in age existed among outbreak related (August and Sep-
tember 2001) as compared to non-outbreak (other study
surveillance periods) related patients with Cryptosporidium
sp. infections. The median (IQR) age of outbreak related
patients were significantly lower than that of non-out-
break patients (7.5 years; IQR; 3.5–11 years vs. 10 years;
IQR, 4–23 years, p = 0.02). Ninety-two (81/88) percent of
the outbreak patients were < 20 years of age as compared
to 66% (56/85) of non-outbreak patients (p < 0.0001).BMC Infectious Diseases 2005, 5:72 http://www.biomedcentral.com/1471-2334/5/72
Page 4 of 9
(page number not for citation purposes)
Males were at slightly higher risk overall for development
of cryptosporidiosis as compared to females (6.9 vs. 5.1
per 100,000/yr; RR 1.35; 95% CI, 0.99–1.84, p = 0.053)
which was similar to the trend found for giardiasis. No
significant association was observed between gender and
the presence of the outbreak.
Discussion
This is the first study that has investigated the occurrence
and demographic risk factors for acquiring Giardia sp. and
Cryptosporidium sp. infections using a population-based
methodology in Canada. Population-based methodolo-
gies are widely viewed as optimal designs for establishing
the burden of disease because selection bias is minimized
since all patients in a defined geographic area are included
in surveillance [21-23]. The American Centers for Disease
Control (CDC) that is recognized as a leader in infectious
disease epidemiology utilizes a very similar methodology
for their Active Bacterial Core Surveillance program http:/
/www.cdc.gov/ncidod/dbmd/abcs/methstart.htm.
If adequate denominator data is available then incidence
rates may be calculated from population-based datasets.
The rates we determined in this study should be viewed as
the minimum incidence because multiple stool sampling
is not a standard practice in our region, and many patients
may have had these diseases without having a stool sam-
ple submitted for parasitological testing. In addition, cer-
tain groups that seek medical attention less frequently
may be underrepresented using a population-based labo-
ratory surveillance approach (i.e., shut-in elderly, intrave-
nous drug users, those with mental illness etc.), but these
limitations would also be a reality of other approaches.
However, even considering these limitations, Giardia and
Cryptosporidium result in a significant disease burden in
Calgary. We found that infections with Giardia sp. and/or
Cryptosporidium sp. were common in our region.
Epidemiological analysis of regional stool parasitological
testing data over a two-year period demonstrated that
these two parasites were the most commonly identified
pathogenic enteric protozoa in the Calgary Health Region,
which is similar to the rates previously reported in the
United States [1,15,24]. Population-based studies in the
United States have indicated rates of Giardia sp. infections
ranging from 0.98 to 42.3 cases per 100,000 per year with
an average of 9.5 cases per 100,000 per year [1]. However,
true population based rates for Cryptosporidum sp. based
Seasonal distribution of Giardia sp. infections in the Calgary Health Region Figure 1
Seasonal distribution of Giardia sp. infections in the Calgary Health Region.
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on laboratory surveillance data have been difficult to
determine in the United States because most diagnostic
laboratories do not routinely perform stool parasitologi-
cal procedures that would allow detection of this parasite.
A recent survey indicates that most laboratories only ana-
lyze stool parasitological samples for the presence of
Cryptosporidium sp., Cyclspora sp. and Microsporidium sp. on
specific request of the physician [25]. Based on laboratory
surveillance data from clinical microbiology laboratories,
there were a total of 443 cases of cryptosporidiosis
reported to the CDC in the United States in 2003 [26]
which is much lower than that expected from population-
based estimates of infection rates. Estimates for the Crypt-
osporidium sp. infection rates for the general population
(i.e., 1 – 400 cases per 100,000) in the United States have
been based on US-wide water monitoring data [27]. The
population-based rate of giardiasis and cryptosporidiosis
cases in Calgary is similar to the national average rate per
100,000 reported from the United States. However, the
rate of Cryptosporidium sp. infections found in our region
is well above the proposed acceptable annual risk level of
1 case of infection per 10,000 [13]. Substantially more
Cryptosporidium sp. infections were found in our region
during the study period. To our knowledge studies con-
ducted to date from Canada have also not been ade-
quately designed to report incidence rates to allow
comparison. The results of our study demonstrate that
Giardia sp. and Cryptosporidium sp. infections are common
with the former occurring at a rate of more than 3 times
more frequently.
We observed a number of similar and contrasting features
among infections due to Giardia and Cryptosporidium sp.
Giardia sp. infections occurred more commonly in late
summer in our region and may be related to water expo-
sure and the increased use of backcountry recreational
areas. On the other hand, there was no apparent yearly
seasonal occurrence of sporadic (i.e. non-outbreak
related) Cryptosporidium sp. infections in our region (Fig-
ure 3). Although few studies of the seasonal incidence of
intestinal parasites have been done, prior reports from
specific geographic locations in the United States suggest
that Cryptosporidium sp. infection is most prevalent in the
spring, while no seasonality was found in Giardia  sp.
infections [28]. Infection with either parasite occurs when
cysts are ingested via contaminated hands, food, and/or
Age and gender specific incidence rates of Giardia sp. infection in the Calgary Health Region Figure 2
Age and gender specific incidence rates of Giardia sp. infection in the Calgary Health Region.
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water or through person-to-person contact. Individual
cases as well as outbreaks have therefore been associated
with improper food handling, exposure to contaminated
water (i.e. municipal sources including swimming pools,
surface and groundwater including those found in beaver
ponds and springs), travel to less developed countries or
close contact with a case (i.e. families, day care centers)
[12,29-33]. Specific risk factors that have recently been
associated with sporadic cryptosporidiosis among immu-
nocompetent persons in the United States include inter-
national travel, contact with cattle, contact with persons
>2 to 11 years of age with diarrhea and freshwater swim-
ming [34]. Temporal investigation of fecal shedding of
Cryptosporidium parvum oocysts in cow-calf herds has also
shown that most fecal shedding of this parasites by
infected cattle is limited to calves 1 to 4 months old so
that the risk of parasitic watershed contamination is great-
est in the spring during calving season [35]. Enteric para-
sitic infection with either Giardia sp. or Cryptosporidium sp.
may also be transmitted through sexual contact and
immunocompromised persons (i.e. acquired immunode-
ficiency syndrome) are particularly at risk of developing
severe persistent infection [36]. Differences in the season-
ality of intestinal parasite prevalence between disparate
geographic locations may therefore be dependent on a
variety of factors including the composition of the popu-
lation and their coming into contact with various contam-
inated water sources (i.e. urban versus rural areas).
Another contrasting feature among these infections was
that the age distribution was different. Giardia sp. infec-
tions, although most commonly infecting children,
occurred across a broad age range (Figure 2). In contrast,
Cryptosporidum sp. infections occurred primarily in young
children. The main commonality amongst these two
infections was that they both tended to more commonly
affect males as compared to females [11,37]. Although
this study did not investigate the risk factors associated
with disease acquisition in various age groups, the demo-
graphics of infection is similar to prior studies
Occurrence of infections with Cryptosporidium sp. in the Calgary Health Region Figure 3
Occurrence of infections with Cryptosporidium sp. in the Calgary Health Region.
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[11,13,34,37]. Young children tend to have a higher rate
of infection with Giardia sp. and/or Cryptosporidium sp.
because of their exposure to contaminated municipal and
rural water sources such as well water and swimming
pools and contact with cases in communal living situa-
tions including day care centers. Epidemiological investi-
gation into the risk factors for enteric infection due to one
or both of these parasites is the focus of future studies in
our region.
Our observation that an outbreak of Cryptosporidium sp.
occurred in the third year of the study demonstrates the
importance of their detection by conducting population-
based studies over extended periods (years). We have pre-
viously raised the theoretical potential for bias in popula-
tion-based studies designed to assess the burden and risk
factors for disease if they are conducted in the setting of an
outbreak [38]. If this study had only been conducted over
a one-year period in 2001 we would have made erroneous
inferences on the occurrence and demographic risk factors
for endemic disease as evidenced by the dramatically dif-
ferent rate in that year and that outbreak patients were
younger. In our opinion it is important that "baseline" or
endemic disease be differentiated from outbreak cases in
the description of the epidemiology of an infectious
disease. We urge authors of other studies to plot cases over
time prior to detect outbreaks prior to description.
Although our study is novel in Canada and provides
important information there are some important limita-
tions that merit discussion. First, this was a laboratory
based study and as a result we did not have detailed infor-
mation on patient clinical variables, treatments, and out-
come. Such information may be of interest and use to
clinicians. Second, we did not have reliable other data on
exposures such as food and water sources, travel, and fam-
ily exposures. These variables are clearly important in
these diseases and have been the focus of other important
investigations in Canadian populations [2,12,29,32].
Finally, we did not have actual addresses for all patients
and used a definition of CHR residency status that may
have resulted in at least some non-CHR residents being
classified as residents in our study. As a result we likely
overestimated the incidence of these infections and may
have made biased assessments of demographic risk factors
to at least some degree [21].
Age and gender specific incidence rates of Cryptosporidium sp. infection in the Calgary Health Region Figure 4
Age and gender specific incidence rates of Cryptosporidium sp. infection in the Calgary Health Region.
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Conclusion
In conclusion, we present the results of active population-
based surveillance for Giardia sp. and Cryptosporidium sp.
in a large Canadian region. Giardiasis was endemic, and
younger individuals and males were at increased risk.
Overall, cryptosporidiosis was much less common than
giardiasis, although a large outbreak of cryptosporidiosis
occurred during surveillance. These data provide impor-
tant information on the occurrence and determinants of
the two most important intestinal parasitoses in Canada.
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